US 11,937,868 B2
Systems, assemblies, and methods for treating a bronchial tree
Martin L. Mayse, Wayzata, MN (US); and Steven C. Dimmer, Bellevue, WA (US)
Assigned to Nuvaira, Inc., Minneapolis, MN (US)
Filed by Nuvaira, Inc., Plymouth, MN (US)
Filed on Dec. 3, 2018, as Appl. No. 16/207,810.
Application 16/207,810 is a continuation of application No. 15/427,685, filed on Feb. 8, 2017, granted, now 10,149,714.
Application 15/427,685 is a continuation of application No. 13/592,075, filed on Aug. 22, 2012, granted, now 9,668,809, issued on Jun. 6, 2017.
Application 13/592,075 is a continuation of application No. 13/452,664, filed on Apr. 20, 2012, granted, now 8,808,280, issued on Aug. 19, 2014.
Application 13/452,664 is a continuation of application No. 13/245,522, filed on Sep. 26, 2011, granted, now 8,226,638, issued on Jul. 24, 2012.
Application 13/245,522 is a continuation of application No. 12/463,304, filed on May 8, 2009, granted, now 8,088,127, issued on Jan. 3, 2012.
Claims priority of provisional application 61/155,449, filed on Feb. 25, 2009.
Claims priority of provisional application 61/106,490, filed on Oct. 17, 2008.
Claims priority of provisional application 61/052,082, filed on May 9, 2008.
Prior Publication US 2019/0105102 A1, Apr. 11, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 18/04 (2006.01); A61B 8/12 (2006.01); A61B 18/12 (2006.01); A61B 18/14 (2006.01); A61B 18/18 (2006.01); A61B 18/24 (2006.01); A61B 34/20 (2016.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61B 18/02 (2006.01); A61N 7/02 (2006.01)
CPC A61B 18/1477 (2013.01) [A61B 8/12 (2013.01); A61B 18/1206 (2013.01); A61B 18/1482 (2013.01); A61B 18/1492 (2013.01); A61B 18/18 (2013.01); A61B 18/1815 (2013.01); A61B 18/24 (2013.01); A61B 34/20 (2016.02); A61B 2017/00022 (2013.01); A61B 2018/00011 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00541 (2013.01); A61B 2018/00577 (2013.01); A61B 18/02 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/143 (2013.01); A61B 2018/1432 (2013.01); A61B 2018/1861 (2013.01); A61N 7/022 (2013.01)] 26 Claims
OG exemplary drawing
 
1. A method of treating at least partial obstruction of an airway caused by excessive intraluminal mucus, mucous glands hypertrophy, or both, the method comprising:
damaging nerve tissue via ablation at a first location along the airway so as to attenuate transmission of signals to and/or from mucous producing cells at a second location along the airway so as to reduce a production of mucous from the mucous producing cells.